Blood Cancer Talks cover image

Episode 20. Management of Myeloma in LMICs

Blood Cancer Talks

CHAPTER

The Importance of Infrastructure for Clinical Trials in India

There are very few in investigator initiated trials. The reason is because of very stringent rules that have been laid down by the regulatory authorities. A hematologist in India, I see AML. I also see thalassemia, emophilia, ITP, autoimmune,. He doesn't think we have dedicated time to do focus research and clinical trial. On top of that, we do not have infrastructure basically to conduct phase one or phase two trials.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner